Literature DB >> 31700907

Predictive role of intraoperative clinicopathological features of the central compartment in estimating lymph nodes metastasis status.

Rong-Hao Sun1,2, Chao Li1, Yu-Qiu Zhou1, Yong-Cong Cai1, Chun-Yan Shui1, Wei Liu3, Xu Wang4, Din-Fen Zeng1, Jian Jiang1, Jing-Qiang Zhu2.   

Abstract

BACKGROUND: To explore the feasibility of immediate assessment, which focuses on clinicopathological characteristics of central lymph nodes (LNs) during operation. Moreover, to analyze the predictive effect of various evaluated indicators on the nature, quantities, and ratios of central lymph node metastasis (LNM) in papillary thyroid carcinoma (PTC), to provide the basis for precise individualized central lymph node dissection (LND).
METHODS: According to the inclusion and exclusion criteria, 1,271 PTC patients were selected in this cohort study. In the study, the clinical and pathological characteristics of the central LNs were evaluated by the treatment groups during the operation, which had a similar therapeutic experience. The parameters including the texture, volume, maximum/vertical meridian, extracapsular infiltration, adhesion or fusion, and nano-carbon staining status of the central LNs were collected. According to the pathological results after the operation, the nature, quantities, and rate of LNM in the central compartment were counted. The relationship between these parameters and metastatic nature, quantities, and ratios was analyzed and compared.
RESULTS: Univariate analysis showed that when the larger size of LNs (especially the maximum meridian >0.9 cm), extracapsular infiltration, adhesion and fusion being found, A higher possibility of LNM in the central compartment (P<0.05), higher number and ratio of metastasis (P<0.05) might be existed. Moreover, more than two positive LNs were more likely to appear. Maximum/vertical meridian <2 and texture hardness could not indicate metastasis (P>0.05) and higher metastasis ratio (P>0.05), but could only be used as a reference for the existence of metastasis (P<0.05). The number of metastatic LNs dissected by carbon nanoparticles during operation could be increased (P<0.05). However, it has no predictive effect on the nature and rate of LNM (P>0.05). Multivariate analysis showed that larger central LNs, the maximum meridian >0.9 cm, extracapsular infiltration, adhesion, and fusion were independent prognostic factors for central LNM (P<0.05), which could be used as a predictor of the properties of central LNs during operation. At the same time, larger LNs, extracapsular infiltration, adhesion and fusion, and nano-carbon black staining were independent predictors of LNM in the central compartment, which are more than two (P<0.05).
CONCLUSIONS: It is practical and feasible to evaluate the clinicopathological features of central LNs immediately during the operation. Intraoperative assessment of central LNs volume, capsular infiltration, maximum/vertical meridian, carbon nano tracking, and adhesion and fusion has predictive effects differently on the nature, quantities, and ratios of central LNM. In order to make an early prediction and advance judgment, surgeons should pay more attention to evaluate clinicopathological features of central LNs during operation, which is conducive to the proper implementation of LND in the central compartment. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Differentiated thyroid carcinoma; central lymph node dissection (central LND); central lymph node metastasis (LNM); clinicopathological features

Year:  2019        PMID: 31700907      PMCID: PMC6803219          DOI: 10.21037/atm.2019.08.01

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  17 in total

1.  Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.

Authors:  Jung Bum Choi; Seul Gi Lee; Min Jhi Kim; Tae Hyung Kim; Eun Jeong Ban; Cho Rok Lee; Jandee Lee; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  Head Neck       Date:  2018-12-10       Impact factor: 3.147

2.  [Association between BRAF V600E mutation and central lymph node metastasis in patients with papillary thyroid carcinoma].

Authors:  Chenlei Shi; Huadong Qin; Chao Ding; Yu Sun; Yichen Lyu; Tiefeng Shi
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2015-02

3.  Clinicopathologic Predictive Factors of Cervical Lymph Node Metastasis in Differentiated Thyroid Cancer.

Authors:  Ronghao Sun; Hua Zhang; Kun Liu; Jinchuan Fan; Guojun Li; Xicheng Song; Chao Li
Journal:  Acta Otorrinolaringol Esp (Engl Ed)       Date:  2017-11-20

Review 4.  Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature.

Authors:  Davide Giordano; Roberto Valcavi; Geoffrey B Thompson; Corrado Pedroni; Luigi Renna; Paolo Gradoni; Verter Barbieri
Journal:  Thyroid       Date:  2012-07-24       Impact factor: 6.568

Review 5.  Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma with Clinically Uninvolved Central Neck Lymph Nodes: A Systematic Review and Meta-analysis.

Authors:  Lawrence Chen; Yi-Hsiu Wu; Chia-Hwa Lee; Hsin-An Chen; El-Wui Loh; Ka-Wai Tam
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

6.  Thyroid functional parameters and correlative autoantibodies as prognostic factors for differentiated thyroid cancers.

Authors:  Chao Li; Wenbin Yu; Jinchuan Fan; Guojun Li; Xiaofeng Tao; Yun Feng; Ronghao Sun
Journal:  Oncotarget       Date:  2016-08-02

7.  Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.

Authors:  Young Jae Ryu; Jin Seong Cho; Jung Han Yoon; Min Ho Park
Journal:  World J Surg Oncol       Date:  2018-10-12       Impact factor: 2.754

8.  Short and Long-Term Potential Role of Carbon Nanoparticles in Total Thyroidectomy with Central Lymph Node Dissection.

Authors:  Shuai Xue; Peiyou Ren; Peisong Wang; Guang Chen
Journal:  Sci Rep       Date:  2018-08-09       Impact factor: 4.379

9.  Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis.

Authors:  Haoyu Ren; Yifan Shen; Daixing Hu; Wei He; Jing Zhou; Yijia Cao; Yu Mao; Yi Dou; Wei Xiong; Qi Xiao; Yuhong Zhang; Xinliang Su
Journal:  Cancer Manag Res       Date:  2018-05-03       Impact factor: 3.989

10.  Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment?

Authors:  Pietro Giorgio Calò; Giuseppe Pisano; Fabio Medas; Jacopo Marcialis; Luca Gordini; Enrico Erdas; Angelo Nicolosi
Journal:  World J Surg Oncol       Date:  2014-05-20       Impact factor: 2.754

View more
  1 in total

1.  Prediction of ipsilateral lateral cervical lymph node metastasis in papillary thyroid carcinoma: a combined dual-energy CT and thyroid function indicators study.

Authors:  Ying Zou; Huanlei Zhang; Wenfei Li; Yu Guo; Fang Sun; Yan Shi; Yan Gong; Xiudi Lu; Wei Wang; Shuang Xia
Journal:  BMC Cancer       Date:  2021-03-04       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.